Drug intelligence / Profile preview

SYH9102

Development stage
Unknown
Lead developer
CSPC Pharmaceutical Group
Modality
Peptides
Administration
Subcutaneous
01

Overview

SYH9102 is a ready-to-use, long-acting goserelin sustained-release injection developed by CSPC Pharmaceutical Group. The active ingredient is goserelin, a gonadotropin-releasing hormone (GnRH) receptor agonist. SYH9102 utilizes CSPC's long-acting delivery platform to form an in-situ drug depot after subcutaneous injection, allowing for once-monthly dosing. Compared to existing marketed long-acting goserelin formulations, SYH9102 uses a finer needle, requires a smaller injection volume, and does not require a specialized implantation needle or complex preparation, which is expected to reduce injection-site pain and improve patient compliance. In September 2026, the National Medical Products Administration (NMPA) of China approved clinical trials for SYH9102 for the treatment of solid tumors. It also has potential applications in estrogen-dependent conditions such as endometriosis.

Other names
goserelin sustained-release injection
02

Targets

GnRHR (Gonadotropin-releasing hormone receptor)LH (Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1)

Beyond the preview

Go deeper on SYH9102.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SYH9102.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call